Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Nov 3, 2011 · 10-Q · 34 days after period end · 0001193125-11-294207
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $2.75M | $2.90M |
| Net Income | -$815.00K | -$1.03M |
| EPS Diluted | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 3, 2011 · 34 d after period end
